TACSTD2 and neoplasm: Through the analysis of 80 TNBC cases, the study reveals a significant association between high TROP-2 expression and unfavorable clinicopathological parameters, such as increased tumor size, advanced nodal involvement, and reduced overall and disease-free survival.